Search research articles
Contact Us
Filters
Showing results (11-20 of 128) with videos related to
Page
of 13
Sort By:
European Journal of Neurology
|
June 11, 1999
A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon)
F Forette, R Anand, G Gharabawi
La Nouvelle Presse Medicale
|
May 7, 1977
[Long term hospitalization in France. Current data and perspectives]
F Forette, J Vignalou, P Berthaux
Presse Medicale (Paris, France : 1983)
|
July 22, 1992
[Prevention of pathological aging. The arterial hypertension example]
F Forette, P Bert, V Breuil
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
August 1, 1997
[Isolated systolic hypertension and cognitive function in the aged. Experience of the Syst-Eur study]
M L Seux, L Thijs, F Forette
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
September 1, 1994
Are calcium antagonists the best option in elderly hypertensives?
F Forette, P Bert, A S Rigaud
The Journal of Nutrition, Health & Aging
|
September 7, 2010
Implications of the Impact Survey for payors across Europe
F Forette, A Padovani, K Berthet, et al.
Therapie
|
March 21, 1998
[Role of clinical trials in memory clinics]
H Allain, V Baudoin, B Dubois, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
September 16, 1999
[Treatment of isolated systolic arterial hypertension and prevention of dementia in aged patients. The Syst-Eur multicenter study]
M L Seux, J A Staessen, F Forette
Presse Medicale (Paris, France : 1983)
|
February 5, 1994
[Treatment of arterial hypertension in elderly patients. Value and indications]
P Bert, F Forette, A S Rigaud, et al.
La Revue De Medecine Interne
|
November 7, 2001
[Cerebral complications of hypertension in the elderly]
A S Rigaud, O Hanon, P Bouchacourt, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 128) with videos related to
Sort By:
Page
of 13
European Journal of Neurology
|
June 11, 1999
A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon)
F Forette, R Anand, G Gharabawi
La Nouvelle Presse Medicale
|
May 7, 1977
[Long term hospitalization in France. Current data and perspectives]
F Forette, J Vignalou, P Berthaux
Presse Medicale (Paris, France : 1983)
|
July 22, 1992
[Prevention of pathological aging. The arterial hypertension example]
F Forette, P Bert, V Breuil
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
August 1, 1997
[Isolated systolic hypertension and cognitive function in the aged. Experience of the Syst-Eur study]
M L Seux, L Thijs, F Forette
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
September 1, 1994
Are calcium antagonists the best option in elderly hypertensives?
F Forette, P Bert, A S Rigaud
The Journal of Nutrition, Health & Aging
|
September 7, 2010
Implications of the Impact Survey for payors across Europe
F Forette, A Padovani, K Berthet, et al.
Therapie
|
March 21, 1998
[Role of clinical trials in memory clinics]
H Allain, V Baudoin, B Dubois, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
September 16, 1999
[Treatment of isolated systolic arterial hypertension and prevention of dementia in aged patients. The Syst-Eur multicenter study]
M L Seux, J A Staessen, F Forette
Presse Medicale (Paris, France : 1983)
|
February 5, 1994
[Treatment of arterial hypertension in elderly patients. Value and indications]
P Bert, F Forette, A S Rigaud, et al.
La Revue De Medecine Interne
|
November 7, 2001
[Cerebral complications of hypertension in the elderly]
A S Rigaud, O Hanon, P Bouchacourt, et al.
Page
of 13